Genus plc (LON:GNS)

Market Cap	1.99B
Revenue (ttm)	672.80M +0.6%
Net Income	19.30M +144.3%
EPS	0.29 +142.9%
Shares Out	66.91M
PE Ratio	102.77
Forward PE	29.82
Dividend	0.32 (1.11%)
Ex-Dividend Date	Nov 6, 2025

Volume	354,062
Average Volume	197,380
Open	2,900.00
Previous Close	2,895.00
Day's Range	2,870.00 - 2,985.00
52-Week Range	1,548.00 - 3,228.80
Beta	0.78
RSI	72.06
Earnings Date	Feb 26, 2026

About Genus

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1994
• Employees: 3,190
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GNS

Financial Performance

In 2025, Genus's revenue was 672.80 million, an increase of 0.60% compared to the previous year's 668.80 million. Earnings were 19.30 million, an increase of 144.30%.